Plasma Glycoproteomic Biomarkers Identify Metastatic Melanoma Patients with Reduced Clinical Benefit from Immune Checkpoint Inhibitor Therapy
Frontiers in Immunology(2023)
Key words
glycosylation,immune checkpoint inhibitors,biomarker,liquid biopsy,glycoproteomics,melanoma
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined